ArticleCureus2026
Lymphocytic Vasculopathy With Cytoplasmic Antineutrophil Cytoplasmic Antibody Positivity After Upper Respiratory Infection: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cutaneous manifestations of vasculitic or vasculopathic processes can pose a diagnostic challenge, particularly when systemic symptoms are absent. We report a case of an adult patient who presented with nonpainful petechiae and blue-purple discoloration of the lower extremities three days after a self-limited upper respiratory infection. Laboratory testing revealed elevated erythrocyte sedimentation rate, white blood cell count, and C-reactive protein, as well as positive cytoplasmic antineutrophil cytoplasmic antibody (c-ANCA) titers. No other systemic findings or organ involvement were identified. A punch biopsy of the affected skin demonstrated vascular changes with a differential diagnosis that included lymphocytic vasculopathy. The patient was managed with short-course systemic corticosteroids and close observation as the lesions gradually resolved without complications. This case highlights an atypical, skin-limited c-ANCA-associated lymphocytic vasculopathy, emphasizing the importance for physicians to maintain vigilance for subtle cutaneous signs of autoimmune or inflammatory disease even in the absence of systemic involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.